Danaher Corporation (NYSE:DHR) Stock Position Increased by Flossbach Von Storch SE

Flossbach Von Storch SE lifted its position in Danaher Corporation (NYSE:DHR - Free Report) by 5.7% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,920,603 shares of the conglomerate's stock after buying an additional 209,865 shares during the period. Danaher comprises 3.5% of Flossbach Von Storch SE's holdings, making the stock its 11th largest position. Flossbach Von Storch SE owned 0.55% of Danaher worth $803,724,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC acquired a new position in shares of Danaher during the fourth quarter worth $27,000. GHP Investment Advisors Inc. raised its holdings in shares of Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after acquiring an additional 99 shares during the last quarter. Sierra Ocean LLC raised its holdings in shares of Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after acquiring an additional 76 shares during the last quarter. Hurley Capital LLC purchased a new stake in Danaher in the 4th quarter valued at about $34,000. Finally, Smallwood Wealth Investment Management LLC purchased a new stake in Danaher in the 1st quarter valued at about $31,000. Institutional investors own 79.05% of the company's stock.

Danaher Price Performance

DHR traded down $0.71 on Friday, hitting $204.80. 2,369,010 shares of the company were exchanged, compared to its average volume of 3,501,538. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.43. The business's fifty day moving average is $195.94 and its 200 day moving average is $206.65. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The firm has a market capitalization of $146.57 billion, a P/E ratio of 39.77, a price-to-earnings-growth ratio of 2.82 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. The company had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a net margin of 15.81% and a return on equity of 10.80%. As a group, sell-side analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.63%. Danaher's dividend payout ratio (DPR) is 24.85%.

Insider Buying and Selling at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president directly owned 15,179 shares in the company, valued at $3,005,442. This represents a 51.01% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman owned 3,105,808 shares in the company, valued at $611,036,665.92. This trade represents a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on DHR. Jefferies Financial Group lowered their price objective on Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a research report on Tuesday, April 22nd. TD Cowen boosted their price objective on shares of Danaher from $240.00 to $248.00 and gave the company a "buy" rating in a research report on Wednesday, April 23rd. Stifel Nicolaus upgraded shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 price objective on the stock in a report on Friday, March 14th. Evercore ISI dropped their target price on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research note on Tuesday. Finally, Argus lowered their price objective on shares of Danaher from $260.00 to $240.00 in a research report on Wednesday, April 23rd. Three research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the stock. According to data from MarketBeat.com, Danaher presently has a consensus rating of "Moderate Buy" and a consensus target price of $248.43.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.